I appreciate this @jama.com commentary by Knox and @asarpatwari.bsky.social.
I'm among the skeptics of the 340B program as it currently operates, but it appears this proposed pilot would not address the major issues.
jamanetwork.com/journals/jam...
This Viewpoint presents the history of the Health Resources & Services Administration (HRSA) 340B Drug Pricing Program and 340B Rebate Model Pilot Program, summarizes their controversies and limit...
